{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:04:34Z","timestamp":1761609874335},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11926-008-0039-0","type":"journal-article","created":{"date-parts":[[2008,10,23]],"date-time":"2008-10-23T19:02:25Z","timestamp":1224788545000},"page":"249-255","source":"Crossref","is-referenced-by-count":22,"title":["Gout and coronary artery disease: Epidemiologic clues"],"prefix":"10.1007","volume":"10","author":[{"given":"Eswar","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,24]]},"reference":[{"key":"39_CR1","first-page":"160","volume-title":"A System of Medicine by Many Writers","author":"W. Roberts","year":"1897","unstructured":"Roberts W: Gout. In A System of Medicine by Many Writers. Edited by Allbutt T. London: Macmillan; 1897:160."},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-66-5-851","volume":"66","author":"T.G. Benedek","year":"1967","unstructured":"Benedek TG: Correlations of serum uric acid and lipid concentrations in normal, gouty, and atherosclerotic men. Ann Intern Med 1967, 66:851\u2013861.","journal-title":"Ann Intern Med"},{"key":"39_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00000441-197012000-00002","volume":"260","author":"T.G. Benedek","year":"1970","unstructured":"Benedek TG, Sunder JH: Comparisons of serum lipid and uric acid content in white and Negro men. Am J Med Sci. 1970, 260:331\u2013340.","journal-title":"Am J Med Sci"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0954-6820.1950.tb17139.x","volume":"139","author":"E. Ask-Upmark","year":"1950","unstructured":"Ask-Upmark E, Adner L: Coronary infarction and gout. Acta Med Scand 1950, 139:1\u20136.","journal-title":"Acta Med Scand"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ije\/11.1.71","volume":"11","author":"M.J. Gardner","year":"1982","unstructured":"Gardner MJ, Power C, Barker DJ, Padday R: The prevalence of gout in three English towns. Int J Epidemiol 1982, 11:71\u201375.","journal-title":"Int J Epidemiol"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"H.K. Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM: Pathogenesis of gout. Ann Intern Med 2005, 143:499\u2013516.","journal-title":"Ann Intern Med"},{"key":"39_CR7","first-page":"S656","volume":"52","author":"E. Krishnan","year":"2005","unstructured":"Krishnan E, Griffith C, Kwoh C: Burden of illness from gout in ambulatory care in the United States. Arthritis Rheum 2005, 52:S656.","journal-title":"Arthritis Rheum"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjmed.2005.03.043","volume":"118","author":"J.F. Baker","year":"2005","unstructured":"Baker JF, Krishnan E, Chen L, Schumacher HR: Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005, 118:816\u2013826.","journal-title":"Am J Med"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0895-4356(88)90127-8","volume":"41","author":"R.D. Abbott","year":"1988","unstructured":"Abbott RD, Brand FN, Kannel WB, Castelli WP: Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988, 41:237\u2013242.","journal-title":"J Clin Epidemiol"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","volume":"157","author":"A.C. Gelber","year":"1997","unstructured":"Gelber AC, Klag MJ, Mead LA, et al.: Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med 1997, 157:1436\u20131440.","journal-title":"Arch Intern Med"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","volume":"54","author":"E. Krishnan","year":"2006","unstructured":"Krishnan E, Baker JF, Furst DE, Schumacher HR: Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006, 54:2688\u20132696.","journal-title":"Arthritis Rheum"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","volume":"116","author":"H.K. Choi","year":"2007","unstructured":"Choi HK, Curhan G: Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007, 116:894\u2013900.","journal-title":"Circulation"},{"key":"39_CR13","first-page":"707","volume-title":"Epidemiological background and design: the Framingham Study. Proceedings of the American Statistical Association sesquicentennial invited paper sessions","author":"R.B. D\u2019Agostino","year":"1989","unstructured":"D\u2019Agostino RB, Kannel WB: Epidemiological background and design: the Framingham Study. Proceedings of the American Statistical Association sesquicentennial invited paper sessions. Alexandria, Va: American Statistical Association; 1989:707\u2013718."},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"S.L. Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT, et al.: Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895\u2013900.","journal-title":"Arthritis Rheum"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3346\/jkms.2005.20.6.1029","volume":"20","author":"Y.H. Rho","year":"2005","unstructured":"Rho YH, Choi SJ, Lee YH, et al.: The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 2005, 20:1029\u20131033.","journal-title":"J Korean Med Sci"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1053-2498(00)00175-3","volume":"19","author":"A.E. Wluka","year":"2000","unstructured":"Wluka AE, Ryan PF, Miller AM, et al.: Post-cardiac transplantation gout: incidence of therapeutic complications. J Heart Lung Transplant 2000, 19:951\u2013956.","journal-title":"J Heart Lung Transplant"},{"key":"39_CR17","first-page":"1350","volume":"29","author":"A.G. Fam","year":"2002","unstructured":"Fam AG: Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002, 29:1350\u20131355.","journal-title":"J Rheumatol"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0895-7061(96)00098-2","volume":"9","author":"E. Muscelli","year":"1996","unstructured":"Muscelli E, Natali A, Bianchi S, et al.: Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996, 9:746\u2013752.","journal-title":"Am J Hypertens"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/hrt.78.2.147","volume":"78","author":"S.G. Wannamethee","year":"1997","unstructured":"Wannamethee SG, Shaper AG, Whincup PH: Serum urate and the risk of major coronary heart disease events. Heart 1997, 78:147\u2013153.","journal-title":"Heart"},{"key":"39_CR20","doi-asserted-by":"crossref","unstructured":"Krishnan E, Svendsen K, Neaton J, et al.: Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008 (in press).","DOI":"10.1001\/archinte.168.10.1104"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"T.R. Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, et al.: Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999. Ann Rheum Dis 2005, 64:267\u2013272.","journal-title":"Ann Rheum Dis"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10067-006-0292-4","volume":"26","author":"S.Y. Chen","year":"2007","unstructured":"Chen SY, Chen CL, Shen ML: Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol 2007, 26:308\u2013313.","journal-title":"Clin Rheumatol"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00291235","volume":"78","author":"G.A. Ferns","year":"1988","unstructured":"Ferns GA, Lanham J, Dieppe P, Galton DJ: A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet 1988, 78:55\u201359.","journal-title":"Hum Genet"},{"key":"39_CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.54.5.351","volume":"54","author":"Y. Moriwaki","year":"1995","unstructured":"Moriwaki Y, Yamamoto T, Takahashi S, et al.: Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia. Ann Rheum Dis 1995, 54:351\u2013354.","journal-title":"Ann Rheum Dis"},{"key":"39_CR25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","volume":"165","author":"H.K. Choi","year":"2005","unstructured":"Choi HK, Atkinson K, Karlson EW, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005, 165:742\u2013748.","journal-title":"Arch Intern Med"},{"key":"39_CR26","doi-asserted-by":"crossref","unstructured":"Evaluation of a new oral diuretic agent. Furosemide (Lasix) JAMA 1967, 200:979\u2013980.","DOI":"10.1001\/jama.1967.03120240107021"},{"key":"39_CR27","first-page":"13","volume":"19","author":"E.W. Sanderson","year":"1966","unstructured":"Sanderson EW: Gout as a complication of oral diuretic therapy. S D J Med 1966, 19:13\u201318.","journal-title":"S D J Med"},{"key":"39_CR28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archinte.1965.03870020052012","volume":"116","author":"E.E. Velayos","year":"1965","unstructured":"Velayos EE, Smyth CJ: Urate diuretic therapy in chronic gout; a comparative study of probenecid and sulfinpyrazone. Arch Intern Med 1965, 116:212\u2013219.","journal-title":"Arch Intern Med"},{"key":"39_CR29","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894:i\u2013xii, 1\u2013253."},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007611-195001000-00019","volume":"43","author":"H.T. Engelhardt","year":"1950","unstructured":"Engelhardt HT, Wagner EL: Gout, diabetes mellitus and obesity, a poorly appreciated syndrome. South Med J 1950, 43:51\u201353.","journal-title":"South Med J"},{"key":"39_CR31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.1954.02950060017007","volume":"156","author":"E.F. Traut","year":"1954","unstructured":"Traut EF, Knight AA, Szanto PB, Passerelli EW: Specific vascular changes in gout. J Am Med Assoc 1954, 156:591\u2013593.","journal-title":"J Am Med Assoc"},{"key":"39_CR32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.bor.0000209435.89720.7c","volume":"18","author":"T.R. Mikuls","year":"2006","unstructured":"Mikuls TR, Saag KG: New insights into gout epidemiology. Curr Opin Rheumatol 2006, 18:199\u2013203.","journal-title":"Curr Opin Rheumatol"},{"key":"39_CR33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1471-4892(02)00143-1","volume":"2","author":"M.H. Alderman","year":"2002","unstructured":"Alderman MH: Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002, 2:126\u2013130.","journal-title":"Curr Opin Pharmacol"},{"key":"39_CR34","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.ki.5000391","volume":"69","author":"T. Nakagawa","year":"2006","unstructured":"Nakagawa T, Kang DH, Feig D, et al.: Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int 2006, 69:1722\u20131725.","journal-title":"Kidney Int"},{"key":"39_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2006.04.016","volume":"192","author":"N. Ishizaka","year":"2007","unstructured":"Ishizaka N, Ishizaka Y, Toda E, et al.: Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 2007, 192:131\u2013137.","journal-title":"Atherosclerosis"},{"key":"39_CR36","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"G.K. Hansson","year":"2005","unstructured":"Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685\u20131695.","journal-title":"N Engl J Med"},{"key":"39_CR37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.ATV.20.4.901","volume":"20","author":"L.H. Kuller","year":"2000","unstructured":"Kuller LH, Tracy RP: The role of inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2000, 20:901.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"39_CR38","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"P.M. Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836\u2013843.","journal-title":"N Engl J Med"},{"key":"39_CR39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"P.M. Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973\u2013979.","journal-title":"N Engl J Med"},{"issue":"Suppl1","key":"39_CR40","first-page":"S9","volume":"10","author":"P.M. Ridker","year":"1999","unstructured":"Ridker PM: Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 1999, 10(Suppl 1):S9\u201312.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"39_CR41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199408183310709","volume":"331","author":"R.W. Alexander","year":"1994","unstructured":"Alexander RW: Inflammation and coronary artery disease. N Engl J Med 1994, 331:468\u2013469.","journal-title":"N Engl J Med"},{"key":"39_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ahj.2004.12.019","volume":"150","author":"A.Y. Tiong","year":"2005","unstructured":"Tiong AY, Brieger D: Inflammation and coronary artery disease. Am Heart J 2005, 150:11\u201318.","journal-title":"Am Heart J"},{"key":"39_CR43","doi-asserted-by":"crossref","first-page":"10E","DOI":"10.1016\/S0002-9149(97)00483-9","volume":"80","author":"F. Crea","year":"1997","unstructured":"Crea F, Biasucci LM, Buffon A, et al.: Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol 1997, 80:10E\u201316E.","journal-title":"Am J Cardiol"},{"key":"39_CR44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.1780340203","volume":"34","author":"E. Pascual","year":"1991","unstructured":"Pascual E: Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout. Arthritis Rheum 1991, 34:141\u2013145.","journal-title":"Arthritis Rheum"},{"key":"39_CR45","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/rheumatology\/keh640","volume":"44","author":"N. Dalbeth","year":"2005","unstructured":"Dalbeth N, Haskard DO: Mechanisms of inflammation in gout. Rheumatology (Oxford) 2005, 44:1090\u20131096.","journal-title":"Rheumatology (Oxford)"},{"key":"39_CR46","first-page":"435","volume":"32","author":"P.H. Dessein","year":"2005","unstructured":"Dessein PH, Joffe BI, Veller MG, et al.: Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005, 32:435\u2013442.","journal-title":"J Rheumatol"},{"key":"39_CR47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","volume":"25","author":"N.R. Madamanchi","year":"2005","unstructured":"Madamanchi NR, Vendrov A, Runge MS: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29\u201338.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"39_CR48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1538-7836.2004.01085.x","volume":"3","author":"N.R. Madamanchi","year":"2005","unstructured":"Madamanchi NR, Hakim ZS, Runge MS: Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemost 2005, 3:254\u2013267.","journal-title":"J Thromb Haemost"},{"key":"39_CR49","doi-asserted-by":"crossref","first-page":"H1328","DOI":"10.1152\/ajpheart.00461.2006","volume":"292","author":"A.P. Saliaris","year":"2007","unstructured":"Saliaris AP, Amado LC, Minhas KM, et al.: Chronic allopurinol administration ameliorates maladaptive alterations in calcium cycling proteins and {beta}-adrenergic hyporesponsiveness in heart failure. Am J Physiol Heart Circ Physiol 2007, 292:H1328\u2013H1335.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"39_CR50","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","volume":"114","author":"J. George","year":"2006","unstructured":"George J, Carr E, Davies J, et al.: High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006, 114:2508\u20132516.","journal-title":"Circulation"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0039-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-008-0039-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-008-0039-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:49Z","timestamp":1559436589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-008-0039-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s11926-008-0039-0","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}